Assessing Multiple Medication Use With Probabilities of Benefits and Harms
Bibliographic Data
| ID | 12797691 |
|---|---|
| Authors | Terrence E Murphy (0000-0002-9687-8998, Yale School of Medicine,, corresponding author), Joseph V Agostini (Yale School of Medicine and VA Connecticut Healthcare System), Peter H van Ness (Yale School of Medicine), Peter Peduzzi (0000-0002-7634-6804, Yale School of Medicine and VA Connecticut Healthcare System), Mary E Tinetti (0000-0003-0940-9702, Yale School of Medicine), Heather Allore (0000-0001-7685-8175, Yale University), Heather G Allore (Yale School of Medicine) |
| Year | 2008 |
| Volume | 20 |
| Issue | 6 |
| Pages | 694-709 |
| Publication date | 2008-07-15 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Aging and Health (JOURNAL) |
| Journal identifiers | ISSN: 1552-6887 • E-ISSN: 0898-2643 |
| Publisher | SAGE Publishing (PUBLISHER • US) |
| DOI | 10.1177/0898264308321006 |
| PMID | 18625759 |
| PMCID | PMC3477770 |
| OpenAlex | W2154844428 |
| Language | EN |
| Citations received | 2 |
| References cited | 28 |
The framework proposed provides a simple method for considering the trade-offs involved in prescribing multiple medications. It can be adapted to include additional parameters representing severity of condition, prioritization of outcomes, patient preferences, dosages, and medication interactions. Inconsistent reporting in the medical literature of data about benefits and harms of medications, dosages, and interactions constitutes its primary limitation
Actuarial science · Business · Context (archaeology · Dose · Economics · Machine learning · Management science · Prioritization · Risk analysis (engineering · Value (mathematics · Yield (engineering · Computer Science · Health Systems, Economic Evaluations, Quality of Life · Medication Adherence and Compliance · Medicine · Pharmaceutical Practices and Patient Outcomes · Pharmacology
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,33 |
| Citation span | 2020 - 2021 (2) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 2 |